CONMED Corp — Director's Dealing 2017

Jun 2, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2017-06-01

Reporting Person: Cohen Heather L (EVP CORP HR)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-01	Common Stock	M	800	—	Acquired	12091	Direct
2017-06-01	Common Stock	F	296	$51.90	Disposed	11795	Direct
2017-06-01	Common Stock	M	800	—	Acquired	12595	Direct
2017-06-01	Common Stock	F	296	$51.90	Disposed	12299	Direct
2017-06-01	Common Stock	M	520	—	Acquired	12819	Direct
2017-06-01	Common Stock	F	193	$51.90	Disposed	12626	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-01	Rsus (restricted Stock Units)	$0	M	800	Disposed	2022-06-01	Common Stock (800)	Direct
2017-06-01	Rsus (restricted Stock Units)	$0	M	800	Disposed	2023-06-01	Common Stock (800)	Direct
2017-06-01	Rsus (restricted Stock Units)	$0	M	520	Disposed	2024-06-01	Common Stock (520)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.